» Articles » PMID: 22096659

The Emergence of LncRNAs in Cancer Biology

Overview
Journal Cancer Discov
Specialty Oncology
Date 2011 Nov 19
PMID 22096659
Citations 1002
Authors
Affiliations
Soon will be listed here.
Abstract

The discovery of numerous noncoding RNA (ncRNA) transcripts in species from yeast to mammals has dramatically altered our understanding of cell biology, especially the biology of diseases such as cancer. In humans, the identification of abundant long ncRNA (lncRNA) >200 bp has catalyzed their characterization as critical components of cancer biology. Recently, roles for lncRNAs as drivers of tumor suppressive and oncogenic functions have appeared in prevalent cancer types, such as breast and prostate cancer. In this review, we highlight the emerging impact of ncRNAs in cancer research, with a particular focus on the mechanisms and functions of lncRNAs.

Citing Articles

Improving IL12 immunotherapy in glioblastoma by targeting the long noncoding RNA INCR1.

Saini S, Gadet J, Freeman G, Chiocca E, Mineo M J Neurooncol. 2025; .

PMID: 40035950 DOI: 10.1007/s11060-025-04978-2.


LINC00626 drives tamoxifen resistance in breast cancer cells by interaction with UPF1.

Yuan H, Zhou L, Hu W, Yang M Sci Rep. 2025; 15(1):2997.

PMID: 39848992 PMC: 11757752. DOI: 10.1038/s41598-025-86287-2.


Dysregulation of Long Non-coding RNAs-the Novel lnc in Metal Toxicity and Carcinogenesis.

Wang Z, Wang P, Yang C Curr Environ Health Rep. 2024; 12(1):3.

PMID: 39715843 PMC: 11755759. DOI: 10.1007/s40572-024-00468-1.


Prognostic model based on disulfidptosis-related lncRNAs for predicting survival and therapeutic response in bladder cancer.

Han L, Yang H, Jiang X, Zhou Z, Ge C, Yu K Front Immunol. 2024; 15:1512203.

PMID: 39687628 PMC: 11647029. DOI: 10.3389/fimmu.2024.1512203.


Ailanthone disturbs cross-talk between cancer cells and tumor-associated macrophages via HIF1-α/LINC01956/FUS/β-catenin signaling pathway in glioblastoma.

Deng X, Zhang Q, Jin F, Lu F, Duan G, Han L Cancer Cell Int. 2024; 24(1):397.

PMID: 39639311 PMC: 11619249. DOI: 10.1186/s12935-024-03594-w.


References
1.
He Y, Vogelstein B, Velculescu V, Papadopoulos N, Kinzler K . The antisense transcriptomes of human cells. Science. 2008; 322(5909):1855-7. PMC: 2824178. DOI: 10.1126/science.1163853. View

2.
Ganesan S, Silver D, Greenberg R, Avni D, Drapkin R, Miron A . BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell. 2002; 111(3):393-405. DOI: 10.1016/s0092-8674(02)01052-8. View

3.
Brown C, Ballabio A, Rupert J, Lafreniere R, Grompe M, Tonlorenzi R . A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature. 1991; 349(6304):38-44. DOI: 10.1038/349038a0. View

4.
Braconi C, Kogure T, Valeri N, Huang N, Nuovo G, Costinean S . microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene. 2011; 30(47):4750-6. PMC: 4292930. DOI: 10.1038/onc.2011.193. View

5.
Weksberg R, Nishikawa J, Caluseriu O, Fei Y, Shuman C, Wei C . Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet. 2001; 10(26):2989-3000. DOI: 10.1093/hmg/10.26.2989. View